Skip to Content
 

News: Urologic Cancers

Hand-held robot points to less invasive prostate surgery

Friday, July 19th, 2019

Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.

VISE team seeks to develop new robot to ease prostatectomies

Thursday, April 25th, 2019

The Vanderbilt Institute for Surgery and Engineering (VISE) team of Robert Webster III, PhD, and Duke Herrell, MD, have received a $2.2 million grant from the National Institutes of Health to develop a new surgical robot for endoscopic transurethral prostatectomy.

Society of Urologic Oncology honors Smith’s contributions

Thursday, April 4th, 2019

Joseph “Jay” Smith Jr., MD, professor of Urologic Surgery, has been awarded the 2019 Willet F. Whitmore Jr. Award and Lectureship from the Society of Urologic Oncology (SUO).

Achilles’ heel for kidney cancer

Monday, March 4th, 2019

A recent study found that renal cell carcinoma cells with mutations in an enzyme-encoding gene, SETD2, were sensitive to a drug that inhibits the enzyme PI3K-beta.

Society of Urologic Oncology honors Barocas’ contributions

Monday, February 4th, 2019

Daniel Barocas, MD, MPH, associate professor of Urology, is being recognized with a national award from the Society of Urologic Oncology (SUO) for his efforts to develop urologic cancer quality measures.

Therapy aims to reduce prostate cancer treatment side effects

Friday, December 14th, 2018

Vanderbilt urologic surgeons are offering an alternative therapy for prostate cancer patients considered to be low-to-intermediate risk, a middle ground between active surveillance and aggressive therapy.

Men: What to ask your doctor about prostate cancer screening

Friday, July 6th, 2018

Making sense of the updated guidelines for prostate cancer screening.

Grant bolsters kidney cancer immunotherapy research

Friday, May 11th, 2018

Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

Ingram sees recent cancer diagnosis as second chance

Thursday, April 19th, 2018

Longtime Vanderbilt-Ingram Cancer Center supporter Orrin Ingram opted to take an aggressive approach to treatment when he was diagnosed with prostate cancer.

Rathmell elected to ASCO nominating committee

Tuesday, December 19th, 2017

W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee of the American Society of Clinical Oncology (ASCO).

Next Page »